Decanter C, Robin G
Centre d'AMP du CHRU de Lille, hôpital Jeanne-de-Flandre, 6, rue Eugène-Avinée, 59037 Lille cedex, France.
Gynecol Obstet Fertil. 2013 Oct;41(10):597-600. doi: 10.1016/j.gyobfe.2013.08.007. Epub 2013 Oct 4.
The incidence of cancer in young patients as well as survival rates is steadily increasing. The question of fertility capacity is therefore of great importance regarding the quality of life after cancer. According to the ASCO recommendations, every patient should be advised about the chemotherapy-induced ovarian damage and fertility preservation possibilities. Several options can be discussed: embryo and/or oocytes freezing and ovarian tissue cryopreservation. Fertility preservation techniques are progressing rapidly but it still remains difficult to establish precise flow-charts according to age, marital status, type, dose and timing of chemotherapy.
年轻患者的癌症发病率以及生存率都在稳步上升。因此，生育能力问题对于癌症后的生活质量至关重要。根据美国临床肿瘤学会（ASCO）的建议，应向每位患者告知化疗引起的卵巢损伤以及生育力保存的可能性。可以讨论几种选择：胚胎和/或卵母细胞冷冻以及卵巢组织冷冻保存。生育力保存技术正在迅速发展，但根据年龄、婚姻状况、化疗类型、剂量和时间来制定精确的流程图仍然很困难。
